Skip to main content

Table 6 Percentage of malignant anatomopathology (AP) combining Bethesda with ATA and ACR TI-RADS in 140 indeterminate thyroid nodules

From: ACR TI-RADS and ATA US scores are helpful for the management of thyroid nodules with indeterminate cytology

ATA

Bethesda

Percentage of malignant AP

Very low / low / intermediate

III

7.00%

Very low / low / intermediate

IV/V

35.80%

High

III

50.40%

High

IV/V

88.20%

ACR TI-RADS

 2/3/4a

III

8.10%

 2/3/4a

IV/V

37.50%

 4b/4c/5

III

42.50%

 4b/4c/5

IV/V

83.50%

Back to article page

BMC Endocrine Disorders

ISSN: 1472-6823

Contact us